Denmark imposing '500% tariffs' on Ozempic exports to US? No, that's satire | Fact check
There is no record of Denmark announcing the tariff on Ozempic exports. The social media user who first shared the claim ...
Novo Nordisk Annual Sales Jump on Higher Demand for Obesity Drugs
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...
How Trump tariffs could affect weight loss drugs
Novo Nordisk (NVO), the maker of the popular GLP-1 medications Wegovy and Ozempic, said potential tariffs on Europe imposed ...
Novo Nordisk: Among The Best Opportunities Of The Moment (Rating Upgrade)
Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.
Stock Market Today: S&P 500, Nasdaq Futures Fall; Google, AMD in Focus
Follow along for live updates on stocks, bonds and markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq ...